Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNetscientific Regulatory News (NSCI)

Share Price Information for Netscientific (NSCI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 67.50
Bid: 67.00
Ask: 68.00
Change: 1.00 (1.50%)
Spread: 1.00 (1.493%)
Open: 66.50
High: 67.50
Low: 66.50
Prev. Close: 66.50
NSCI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Wanda Technology Selected by 24Hr HomeCare

23 Sep 2016 07:00

RNS Number : 6195K
NetScientific PLC
23 September 2016
 

 

 

NetScientific plc

("NetScientific" or the "Company" or the "Group")

 

Wanda Technology Selected by 24Hr HomeCare to Improve Care and Reduce Hospital Re-admissions

 

London, UK - 23 September 2016 - NetScientific plc ("NetScientific", AIM:NSCI), the transatlantic healthcare IP commercialisation Group, announces that its portfolio company, Wanda, has been selected by the Los Angeles-based 24Hr HomeCare to provide its predictive analytics and behavioural guidance technology to improve outcomes for at risk-patients and reduce hospital readmissions. 

24Hr HomeCare is a leading provider of high-quality, professional caregiving services to seniors and the disabled, allowing them to continue full, active and healthy lifestyles.

Commenting on the news, François R. Martelet, Chief Executive Officer of NetScientific and Chairman of Wanda, said: "24Hr HomeCare's decision to use Wanda's home-centred care technology to improve outcomes and manage the care of individuals with chronic disease and other high risk conditions is an excellent endorsement of Wanda's growing reputation as a digital healthcare technology."

 

The full text of the announcement issued by Wanda on 22 September 2016 is as follows:

 

 

 

24Hr HomeCare to Deploy Wanda's Home-Centered Care Technology to Improve Care and Reduce Readmissions

 

SAN FRANCISCO -Sept. 22, 2016 - Wanda™, recognized for bringing new and proven technologies to home-centered care, today announced that the Los Angeles-based 24Hr HomeCare has selected Wanda's predictive analytics and behavioral guidance to improve outcomes and enhance patient satisfaction.

 

"As a rapidly growing, nonmedical homecare company, we concluded that it would be a huge asset to implement science-driven technology to monitor the health of our clients between staff visits, as well as to have tools to better predict events that could lead to readmissions," said Zachary Morgan, regional director of strategy and partnerships for 24Hr HomeCare. "After considering other options, Wanda's offering stood out, including their integration of client personality assessment with proven predictive analytics. We also liked the Wanda team's passion for what they were doing and felt a cultural alignment between our organizations."

 

"We are excited to help 24Hr HomeCare advance its efforts to keep their clients safely at home at an affordable cost, especially those with high risk," said Mark Heinemeyer, chief collaboration officer for Wanda. "Wanda provides a perfect complement to 24Hr HomeCare's existing high-quality programs and will assist caregivers as they proactively manage the care of individuals with chronic disease and other high risk conditions. We look forward to a successful partnership that results in excellent care for 24Hr HomeCare customers and reduces the risk of readmissions."

 

24Hr HomeCare is deploying the solution immediately.

 

Wanda representatives will be on hand at the Home Care Association of America 2016 Leadership Conference September 25-28 in Anaheim, CA. Please contact us in advance to learn more about Wanda's innovative solution for home-centered care.

 

- Ends -

 

 

For more information, please contact:

 

NetScientific

François R. Martelet, M.D., CEO

Ian Postlethwaite, CFO

 

Tel: +44 (0)20 3514 1800

 

Consilium Strategic Communications

Mary-Jane Elliott / Chris Gardner /

Jessica Hodgson / Chris Welsh /

Laura Thornton

 

Tel: +44 (0)20 3709 5700

netscientific@consilium-comms.com

 

 

About NetScientific Plc

 

NetScientific is a transatlantic healthcare IP commercialisation Group focused on improving the health and well-being of people with chronic diseases.

For more information, please visit the website at www.netscientific.net

 

About Wanda

San Francisco-based Wanda is dedicated to advancing the effectiveness and efficiency of medicine by using machine learning in place of conventional technologies and by enabling clinicians to make more informed care decisions. Wanda recognizes that remote monitoring and algorithms cannot save lives or reduce hospitalizations unless the individual and their caregivers are promptly informed and highly engaged. Through the collaboration of data science and applied medical research, Wanda has proven that its inline analytics predict preventable events much better than conventional methods. Wanda serves as a diligent companion, providing encouragement and intelligent visual guidance that simplifies and improves lives, while simultaneously helping organizations reduce their care delivery costs. Wanda is a NetScientific portfolio company. More information about Wanda can be found at www.yourwanda.com.

About 24Hr HomeCare

24Hr HomeCare is a Los Angeles-based company that provides high-quality, professional caregiving services to seniors and the disabled, allowing them to continue full, active and healthy lifestyles. Founded by David Allerby, Tyner Brenneman-Slay, and Ryan Iwamoto in 2008, 24Hr HomeCare has expanded to thirteen locations throughout California and Arizona, hiring over 3,000 employees. Services include assistance with personal care, meal preparation, medication reminders, light housekeeping, and transportation services. 24Hr HomeCare was ranked by the Los Angeles Business Journal as the #14 Best Place to Work in 2013, and by Forbes Magazine as the #24 Most Promising Company in America in 2014.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAEAFNAAADKEAF
Date   Source Headline
3rd Nov 20154:29 pmRNSHolding(s) in Company
21st Oct 20151:52 pmRNSPosting of Circular
1st Oct 20157:00 amRNSProposed Placing and Fund Raising to raise c.£20m
1st Oct 20157:00 amRNSHalf Yearly Report
18th Sep 20157:00 amRNSDivestment of Shareholding in Frontier BioSciences
16th Sep 20151:01 pmRNSHolding(s) in Company
15th Sep 20157:00 amRNSVortex BioSciences granted critical patent
9th Sep 20151:00 pmRNSSteve Curd appointed as CEO of Wanda
7th Aug 20157:00 amRNSDivestment of non-core assets to align portfolio
4th Aug 20157:00 amRNSProAxsis launches first-in-class ProteaseTag test
15th Jul 20157:00 amRNSKey patent granted for Glucosense's technology
22nd Jun 20151:19 pmRNSResults of Annual General Meeting
22nd Jun 20157:00 amRNSAGM Statement
5th Jun 20155:46 pmRNSNotification of Major Interest in Shares
5th Jun 20155:42 pmRNSNotification of Major Interest in Shares
5th Jun 20155:38 pmRNSNotification of Major Interest in Shares
5th Jun 20152:00 pmRNSNotification of Major Interest in Shares
5th Jun 20152:00 pmRNSNotification of Major Interest in Shares
28th May 201512:02 pmRNSPDS Biotechnology reports positive Phase I results
18th May 20157:00 amRNSNotice of AGM and Annual Report & Accounts
15th May 20157:00 amRNSCapital Markets Day
11th May 20157:00 amRNSDr. François R. Martelet appointed as CEO
7th May 20157:00 amRNSNetScientific invests in Neumitra
1st May 20157:00 amRNSNetScientific Forms New Digital Health Company
29th Apr 20159:00 amRNSNetScientific Capital Markets Day
1st Apr 20157:00 amRNSChange of Adviser
24th Mar 20157:00 amRNSSignificant Progress in core Portfolio Companies
20th Mar 20152:00 pmRNSNotice of Full Year Results
26th Feb 201510:07 amRNSAppointment of Non-Executive Director
16th Jan 20156:19 pmRNSDirectorate Change
7th Jan 20151:04 pmRNSNetScientific teams up with KU Leuven
7th Jan 20151:04 pmRNSNetScientific invests in DName-iT
15th Dec 20147:00 amRNSNetScientific invests in PDS Biotechnology
11th Dec 20147:00 amRNSNetScientific enters into alliance with Healthbox
8th Dec 20147:00 amRNSNetScientific invests in Breakout Labs' portfolio
17th Nov 20143:36 pmRNSHolding(s) in Company
17th Nov 20141:26 pmRNSHolding(s) in Company
3rd Oct 20147:00 amRNSSubsidiary, Glycotest collaboration with Oncimmune
23rd Sep 20147:00 amRNSHalf Yearly Report
17th Sep 20142:00 pmRNSNotice of Half Yearly Report
29th Jul 20144:23 pmRNSNetScientific announces shareholder name change
23rd Jul 20148:27 amRNSNetScientific Invests in Breakout Labs Companies
21st Jul 201411:43 amRNSTR1 - Notification of Major Interest in Shares
11th Jul 201411:50 amRNSTR1 - Notification of Major Interest in Shares
4th Jul 20142:11 pmRNSNotification of Major Interest In Shares
2nd Jul 20147:00 amRNSResearch Programme in DNA Sequencing
9th Jun 20144:34 pmRNSNetScientific plc
20th May 20145:33 pmRNSResult of AGM
20th May 20147:00 amRNSAGM Statement
19th May 20147:00 amRNSAnnouncement of research agreement with Harvard

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.